Trade Names: | |
Synonyms: | |
Status: | Approved (1967) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | F8A3652H1V |
Parent Compound: | PROPRANOLOL |
InChI Key | ZMRUPTIKESYGQW-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H22ClNO2 |
Molecular Weight | 295.81 |
AlogP | 2.58 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 41.49 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 19.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | - | 1 | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 60 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Esophageal and Gastric Varices | 3 | D004932 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 3 | D013313 | ClinicalTrials |
Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Movement Disorders | 2 | D009069 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Tetralogy of Fallot | 1 | D013771 | ClinicalTrials |
Hemangioma | 1 | D006391 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 8500 |
ChEMBL | CHEMBL1671 |
EPA CompTox | DTXSID3021198 |
FDA SRS | F8A3652H1V |
Guide to Pharmacology | 564 |
KEGG | C07407 |
PDB | SNP |
PubChem | 62882 |
SureChEMBL | SCHEMBL41688 |
ZINC | ZINC00056556 |